JP2009504681A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009504681A5 JP2009504681A5 JP2008526290A JP2008526290A JP2009504681A5 JP 2009504681 A5 JP2009504681 A5 JP 2009504681A5 JP 2008526290 A JP2008526290 A JP 2008526290A JP 2008526290 A JP2008526290 A JP 2008526290A JP 2009504681 A5 JP2009504681 A5 JP 2009504681A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20166405A | 2005-08-11 | 2005-08-11 | |
US11/206,903 US8076288B2 (en) | 2004-02-11 | 2005-08-17 | Hybrid polypeptides having glucose lowering activity |
US11/301,744 US7723471B2 (en) | 2004-02-11 | 2005-12-12 | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
PCT/US2006/031724 WO2007022123A2 (en) | 2005-08-11 | 2006-08-11 | Hybrid polypeptides with selectable properties |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011137014A Division JP5373855B2 (en) | 2005-08-11 | 2011-06-21 | Hybrid polypeptides with selectable properties |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009504681A JP2009504681A (en) | 2009-02-05 |
JP2009504681A5 true JP2009504681A5 (en) | 2009-12-17 |
Family
ID=39662713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008526290A Pending JP2009504681A (en) | 2005-08-11 | 2006-08-11 | Hybrid polypeptides with selectable properties |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP2009504681A (en) |
KR (1) | KR101399178B1 (en) |
CN (1) | CN101296942A (en) |
EA (1) | EA014647B1 (en) |
IL (1) | IL188937A0 (en) |
MX (1) | MX2008002028A (en) |
ZA (1) | ZA200801138B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010118384A2 (en) * | 2009-04-10 | 2010-10-14 | Amylin Pharmaceuticals, Inc. | Amylin agonist compounds for estrogen-deficient mammals |
EP2504021A4 (en) * | 2009-11-23 | 2013-05-15 | Amylin Pharmaceuticals Llc | Polypeptide conjugate |
GB201001333D0 (en) * | 2010-01-27 | 2010-03-17 | Imp Innovations Ltd | Novel compounds and their effects on feeding behaviour |
MX343360B (en) * | 2010-04-27 | 2016-11-03 | Zealand Pharma As | Peptide conjugates of glp-1 receptor agonists and gastrin and their use. |
RU2552221C2 (en) * | 2010-07-15 | 2015-06-10 | Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" | Method of treating obesity and accompanying metabolic disorders and medication for treating obesity and accompanying metabolic disorders |
WO2012162547A2 (en) * | 2011-05-25 | 2012-11-29 | Amylin Pharmaceuticals, Inc. | Long duration dual hormone conjugates |
TWI674270B (en) * | 2012-12-11 | 2019-10-11 | 英商梅迪繆思有限公司 | Glucagon and glp-1 co-agonists for the treatment of obesity |
JP2017532292A (en) * | 2014-08-11 | 2017-11-02 | オルバニー メディカル カレッジ | Myristoylated leptin-related peptides and uses thereof |
KR101689803B1 (en) * | 2015-11-17 | 2016-12-27 | 고려대학교 산학협력단 | Composition for preventing or treating of diabetes or obesity containing Apelin-16 |
US11034745B2 (en) * | 2016-01-04 | 2021-06-15 | Adepthera Llc | Superagonist polypeptide analogs of adrenomedullin and intermedin peptide hormones |
JP6889432B2 (en) * | 2016-04-28 | 2021-06-18 | 学校法人甲南学園 | Resin-fixed peptide |
SG11201901393VA (en) * | 2016-09-02 | 2019-03-28 | Univ Illinois | Kif13b-derived peptide and method of inhibiting angiogenesis |
JP7202011B2 (en) * | 2017-09-13 | 2023-01-11 | キッズウェル・バイオ株式会社 | Anti-RAMP2 antibody |
US10875902B2 (en) | 2018-04-25 | 2020-12-29 | Janssen Pharmaceutica Nv | Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof |
TW202014433A (en) * | 2018-04-25 | 2020-04-16 | 比利時商健生藥品公司 | Glucagon like peptide 1 (glp-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof |
KR102116944B1 (en) * | 2019-09-23 | 2020-05-29 | 주식회사 차메디텍 | Novel peptide derivatives having melanin production inhibitory activity, pharmaceutically acceptable salts thereof, and composition for inhibiting melanin production comprising the same |
CN115960258B (en) * | 2022-09-30 | 2024-01-12 | 广西医科大学附属肿瘤医院 | GLP-1/glucon/Y 2 Receptor triple agonists and uses thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5739106A (en) * | 1995-06-07 | 1998-04-14 | Rink; Timothy J. | Appetite regulating compositions |
EP0910578A2 (en) * | 1996-01-19 | 1999-04-28 | The Board Of Regents, The University Of Texas System | Recombinant expression of proteins from secretory cell lines |
AU1159897A (en) | 1996-11-13 | 1998-06-03 | University Of Cincinnati, The | Analogs of peptide yy and uses thereof |
PL194159B1 (en) * | 1996-12-20 | 2007-05-31 | Amgen Inc | Fusion-type protein ob - compositions and methods |
US6506724B1 (en) * | 1999-06-01 | 2003-01-14 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus |
US6528486B1 (en) * | 1999-07-12 | 2003-03-04 | Zealand Pharma A/S | Peptide agonists of GLP-1 activity |
EP1246638B2 (en) * | 2000-01-10 | 2014-07-30 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for the treatment of hypertriglyceridemia |
WO2002046227A2 (en) * | 2000-12-07 | 2002-06-13 | Eli Lilly And Company | Glp-1 fusion proteins |
EP2275117B1 (en) * | 2001-07-31 | 2016-10-26 | The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services | GLP-1, exendin-4, peptide analogs and uses thereof |
US7192922B2 (en) * | 2002-11-19 | 2007-03-20 | Allegheny-Singer Research Institute | Method of treating left ventricular dysfunction |
US7166575B2 (en) | 2002-12-17 | 2007-01-23 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity |
WO2004056313A2 (en) * | 2002-12-17 | 2004-07-08 | Amylin Pharmaceuticals, Inc. | Prevention and treatment of cardiac arrhythmias |
US20070027073A1 (en) * | 2003-04-08 | 2007-02-01 | Menachem Rubinstein | Long-acting derivatives of pyy agonists |
EP2417980A1 (en) * | 2004-02-11 | 2012-02-15 | Amylin Pharmaceuticals Inc. | Hybrid polypeptides with selectable properties |
-
2006
- 2006-08-11 CN CNA2006800376649A patent/CN101296942A/en active Pending
- 2006-08-11 KR KR1020087005846A patent/KR101399178B1/en not_active IP Right Cessation
- 2006-08-11 EA EA200800548A patent/EA014647B1/en not_active IP Right Cessation
- 2006-08-11 MX MX2008002028A patent/MX2008002028A/en active IP Right Grant
- 2006-08-11 JP JP2008526290A patent/JP2009504681A/en active Pending
-
2008
- 2008-01-22 IL IL188937A patent/IL188937A0/en unknown
- 2008-02-04 ZA ZA200801138A patent/ZA200801138B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0720064A2 (en) | ||
BRMU8603216U8 (en) | ||
BRPI0715824A8 (en) | ||
JP2009504681A5 (en) | ||
BRPI0713487A2 (en) | ||
BR122016023444A2 (en) | ||
BRPI0708307B8 (en) | ||
CH2121272H1 (en) | ||
AT504380A8 (en) | ||
BY9789C1 (en) | ||
CN300727443S (zh) | 蓄电池(ev22) | |
CN300731999S (zh) | 包装盒(美蕾兹1) | |
CN300731986S (zh) | 酒包装箱(四) | |
CN300730207S (zh) | 用于瓷砖的压机 | |
CN300729985S (zh) | 蓝牙耳机(gk-202) | |
CN300725924S (zh) | 童装(3789) | |
CN300729822S (zh) | 婴儿推车(yk-727) | |
CN300729381S (zh) | 饮品罐(洋酒伴侣) | |
CN300729208S (zh) | 调味品容器座(3) | |
CN300728508S (zh) | 骨灰盒(sc-5-c1-4) | |
CN300725925S (zh) | 童装(3791) | |
CN300725915S (zh) | 童装(3728) | |
CN300728170S (zh) | 浴室柜(vg-324) | |
CN300727915S (zh) | 标贴(三) | |
CN300725926S (zh) | 童装(3793) |